RT Journal Article
SR Electronic
T1 Pulmonary Vein Isolation Versus Left Atrial Posterior Wall Isolation with the Cryoballoon Using the Cross-Over Technique in Persistent Atrial Fibrillation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.04.24303746
DO 10.1101/2024.03.04.24303746
A1 Odagiri, Fuminori
A1 Tokano, Takashi
A1 Miyazaki, Tetsuro
A1 Hirabayashi, Koji
A1 Ishi, Kai
A1 Abe, Hiroshi
A1 Ishiwata, Sayaki
A1 Kakihara, Midori
A1 Maki, Masaaki
A1 Matsumoto, Hiroki
A1 Shimai, Ryosuke
A1 Aikawa, Tadao
A1 Takano, Shintaro
A1 Kimura, Yuki
A1 Kuroda, Shunsuke
A1 Isogai, Hiroyuki
A1 Ozaki, Dai
A1 Shiozawa, Tomoyuki
A1 Yasuda, Yuki
A1 Takasu, Kiyoshi
A1 Iijima, Kenichi
A1 Takamura, Kazuhisa
A1 Matsubara, Tomomi
A1 Tabuchi, Haruna
A1 Hayashi, Hidemori
A1 Yokoyama, Ken
A1 Sekita, Gaku
A1 Sumiyoshi, Masataka
A1 Nakazato, Yuji
A1 Minamino, Tohru
YR 2024
UL http://medrxiv.org/content/early/2024/03/06/2024.03.04.24303746.abstract
AB Background The cryoballoon (CB) has recently been used for performing pulmonary vein isolation (PVI) with concomitant left atrial posterior wall isolation (LAPWI). However, successful LAPWI using only the CB is technically challenging. This study aimed to evaluate the feasibility, safety, and efficacy of the cross-over technique, wherein an overlapped ablation is performed by placing the CB from both left and right directions in contact with the roof and bottom of the left atrium (LA).Methods This was a single-center, retrospective, observational study of 194 consecutive patients with persistent atrial fibrillation (PerAF) who underwent a first-time procedure of PVI + PWI (108 patients) or PVI-only (86 patients) using the CB between April 2021 and December 2023. The cross-over technique was applied in all LAPWI using the CB.Results For ablation of the LA roof and bottom, respectively, a mean of 8.6 ± 1.0 (L→R 4.3 ± 1.1 and R→L 4.3 ± 1.1) and 9.1 ± 1.2 (L→R 4.5 ± 1.2 and R→L 4.6 ± 1.6) CB applications were delivered. LAPW was successfully isolated solely using CB in 107 patients (99.1%). The PVI + PWI group, compared to the PVI-only group, had significantly longer procedure time (180.0 ± 42.4 vs. 78.0 ± 22.1 min, P < 0.001). No severe adverse events were observed in either group. During a median follow-up of 19 months, 93.5% and 72.9% of the PVI + PWI and PVI-only groups, respectively, were free from all atrial tachyarrhythmia recurrence (P = 0.011). Cox regression analyses showed LA diameter and PVI + PWI were independent predictors of all atrial tachyarrhythmias recurrence.Conclusions LAPWI performed solely with the CB using the cross-over technique is feasibly, safe, and was independently associated with a significantly higher freedom from recurrence of atrial tachyarrhythmias compared with PVI alone on midterm follow-up in patients with PerAF.WHAT IS KNOWN?The cryoballoon (CB) has recently been used for performing pulmonary vein isolation (PVI) with concomitant left atrial posterior wall isolation (LAPWI). LAPWI using the CB was previously demonstrated to be superior to PVI alone for the treatment of persistent atrial fibrillation (PerAF).However, successful LAPWI using only the CB is technically challenging, and there is no established LAPWI technique or protocol using the CB.WHAT THE STUDY ADDS?LAPWI solely with the CB was successfully performed using the cross-over technique, wherein an overlapped ablation was performed placing the CB from both left to right and right to left directions in contact with the roof and bottom of the LA.This technique achieved a high rate of acute success (99.1%) and freedom from recurrence of atrial tachyarrhythmias (93.5%) on a midterm follow-up without increasing adverse events.The cross-over technique could be considered an effective ablation strategy for LAPWI, especially in difficult cases such as narrow and steeply angled LA roof and bottom.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is a retrospective observational study.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee of Juntendo University Urayasu Hospital. All patients provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRaw data were generated at Juntendo University Urayasu Hospital. Derived data supporting the findings of this study are available from the corresponding author [FO] on request.CBcryoballoonPVIpulmonary vein isolationLAPWIleft atrial posterior wall isolationLAleft atriumPerAFpersistent atrial fibrillationOACsoral anticoagulantsTTEtransthoracic echocardiogramAADsantiarrhythmic drugsGHgastric hypomotilityLETluminal esophageal temperaturePNphrenic nerveCMAPcompound motor action potentialsRFradiofrequencyAPanteroposteriorECGelectrocardiogramATatrial tachycardiaCTIcavotricuspid isthmusCKcreatine kinaseEGDesophagogastroduodenoscopy